Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of David S. Schrump
Introduction: David S. Schrump is a notable inventor based in Chicago, IL, recognized for his significant contributions to cancer research. His work primarily focuses on the development of monoclonal antibodies that have the potential to revolutionize cancer diagnostics and treatment. With one patent to his name, Schrump's innovations are paving the way for advancements in medical science.
Latest Patents: David S. Schrump holds a patent for monoclonal antibodies that specifically recognize galactosyl-globoside. This invention provides a composition useful for diagnosing cancer, specifically targeting the galactosyl-globoside antigen, gal-Gb4. The patent also includes two hybridoma cell lines, designated J309 and D579, which produce monoclonal antibodies that specifically recognize gal-Gb4. Furthermore, the invention outlines a method for diagnosing carcinoma by contacting a sample from a human subject with a composition that recognizes the galactosyl-globoside antigen, allowing for the formation of a detectable complex. This complex can then be quantified and correlated with values from subjects without carcinomas. Additionally, the invention proposes a method for treating carcinoma by administering an effective amount of galactosyl-globoside or an analog, along with a pharmaceutical carrier to stimulate antibody production.
Career Highlights: David S. Schrump is affiliated with the Sloan-Kettering Institute for Cancer Research, where he has made significant strides in cancer research. His work has contributed to a better understanding of cancer diagnostics and treatment options, showcasing his commitment to advancing medical science.
Collaborations: Throughout his career, Schrump has collaborated with esteemed colleagues, including Koichi Furukawa and Hiroshi Yamaguchi. These collaborations have further enhanced the impact of his research and innovations in the field of cancer.
Conclusion: David S. Schrump's innovative work in developing monoclonal antibodies for cancer diagnosis and treatment exemplifies the critical role of inventors in advancing medical research. His contributions are vital in the ongoing fight against cancer, and his patent reflects a significant step forward in the field.